The Discounted Cash Flow (DCF) valuation of InterCure Ltd (INCR.TA) is (6,084.42) ILS. With the latest stock price at 549.60 ILS, the upside of InterCure Ltd based on DCF is -1207.1%.
Based on the latest price of 549.60 ILS and our DCF valuation, InterCure Ltd (INCR.TA) is a sell. selling INCR.TA stocks now will result in a potential gain of 1207.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 8.3% - 41.3% | 24.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (41,775.16) - (3,172.42) | (6,084.42) |
| Upside | -7701.0% - -677.2% | -1207.1% |